Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.54% | $270.99M | €475.49B | 74.46% | 76 Outperform | |
| Roche Holding AG | 2.05% | $157.14M | CHF294.84B | 46.01% | 73 Outperform | |
| AstraZeneca | 1.97% | $150.59M | $323.92B | 30.42% | 80 Outperform | |
| Novartis AG | 1.91% | $146.29M | CHF242.43B | 28.84% | 80 Outperform | |
| HSBC Holdings | 1.86% | $142.50M | £222.90B | 45.63% | 80 Outperform | |
| Nestlé SA | 1.66% | $126.90M | CHF198.29B | 10.92% | 71 Outperform | |
| Shell (UK) | 1.42% | $108.89M | £165.51B | 11.49% | 73 Outperform | |
| Siemens | 1.35% | $103.37M | €191.01B | 9.25% | 74 Outperform | |
| SAP SE | 1.31% | $100.05M | €197.41B | -36.18% | 66 Neutral | |
| Banco Santander | 1.17% | $89.64M | €157.30B | 92.78% | 73 Outperform |